Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Biometrics
|
July 20, 2013
On population size estimators in the Poisson mixture model
Chang Xuan Mao, Nan Yang, Jinhua Zhong
European Journal of Drug Metabolism and Pharmacokinetics
|
December 7, 2018
Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers
Fan Zhang, Yan Li, Jingqiu Hu, et al.
ACS Omega
|
May 27, 2024
CNT@SrTiO<sub>3</sub> Nanocomposites Synthesized by In Situ Reaction for a High-Performance Flexible Supercapacitor
Yue Cao, Shijingmin Li, Jinhua Zhong, et al.
Life Sciences
|
November 26, 2008
Deletion of p75NTR impairs regeneration of peripheral nerves in mice
Xing-Yun Song, Feng-He Zhang, Fiona H Zhou, et al.
Leukemia & Lymphoma
|
July 20, 2022
A phase II study of Zanubrutinib in combination with rituximab in patients with relapsed/refractory aggressive and indolent B-cell lymphoma
Qingyuan Zhang, Rong Tao, Zhenyu Li, et al.
Journal of Alzheimer'S Disease : JAD
|
July 13, 2017
proBDNF Accelerates Brain Amyloid-β Deposition and Learning and Memory Impairment in APPswePS1dE9 Transgenic Mice
Jia Chen, Tao Zhang, Shusheng Jiao, et al.
Brain, Behavior, and Immunity
|
January 20, 2010
ProBDNF inhibits infiltration of ED1+ macrophages after spinal cord injury
Ira Wong, Hong Liao, Xianshu Bai, et al.
Journal of Affective Disorders
|
July 14, 2019
Efficacy and safety of bupropion hydrochloride extended-release versus escitalopram oxalate in Chinese patients with major depressive disorder: Results from a randomized, double-blind, non-inferiority trial
Yifeng Shen, Qian Zhao, Yimin Yu, et al.
BMC Cardiovascular Disorders
|
July 19, 2020
Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis
Mengtao Li, Zhi-Cheng Jing, Yang Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2021
A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia
Gang An, Daobin Zhou, Shu Cheng, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Biometrics
|
July 20, 2013
On population size estimators in the Poisson mixture model
Chang Xuan Mao, Nan Yang, Jinhua Zhong
European Journal of Drug Metabolism and Pharmacokinetics
|
December 7, 2018
Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers
Fan Zhang, Yan Li, Jingqiu Hu, et al.
ACS Omega
|
May 27, 2024
CNT@SrTiO<sub>3</sub> Nanocomposites Synthesized by In Situ Reaction for a High-Performance Flexible Supercapacitor
Yue Cao, Shijingmin Li, Jinhua Zhong, et al.
Life Sciences
|
November 26, 2008
Deletion of p75NTR impairs regeneration of peripheral nerves in mice
Xing-Yun Song, Feng-He Zhang, Fiona H Zhou, et al.
Leukemia & Lymphoma
|
July 20, 2022
A phase II study of Zanubrutinib in combination with rituximab in patients with relapsed/refractory aggressive and indolent B-cell lymphoma
Qingyuan Zhang, Rong Tao, Zhenyu Li, et al.
Journal of Alzheimer'S Disease : JAD
|
July 13, 2017
proBDNF Accelerates Brain Amyloid-β Deposition and Learning and Memory Impairment in APPswePS1dE9 Transgenic Mice
Jia Chen, Tao Zhang, Shusheng Jiao, et al.
Brain, Behavior, and Immunity
|
January 20, 2010
ProBDNF inhibits infiltration of ED1+ macrophages after spinal cord injury
Ira Wong, Hong Liao, Xianshu Bai, et al.
Journal of Affective Disorders
|
July 14, 2019
Efficacy and safety of bupropion hydrochloride extended-release versus escitalopram oxalate in Chinese patients with major depressive disorder: Results from a randomized, double-blind, non-inferiority trial
Yifeng Shen, Qian Zhao, Yimin Yu, et al.
BMC Cardiovascular Disorders
|
July 19, 2020
Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis
Mengtao Li, Zhi-Cheng Jing, Yang Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2021
A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia
Gang An, Daobin Zhou, Shu Cheng, et al.
Page
of 2